Aurora Cannabis Inc. (NYSE: ACB) Q2 2021 earnings call dated Feb. 11, 2021 Corporate Participants: Ananth Krishnan -- Vice President - Corporate Development and Investor
Categories
Health Care
AstraZeneca PLC (AZN) Q4 2020 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q4 2020 earnings call dated Feb. 11, 2021 Corporate Participants: Pascal Soriot -- Chief Executive Officer David Fredrickson -- Executive Vice-President, Oncology
IQVIA Holdings Inc. (IQV) Q4 2020 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE: IQV) Q4 2020 earnings call dated Feb. 10, 2021 Corporate Participants: Andrew Markwick -- Senior Vice President, Investor Relations and
Centene Corp (CNC) Q4 2020 Earnings Call Transcript
Centene Corp (NYSE: CNC) Q4 2020 earnings call dated Feb. 09, 2021. Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance and Investor Relations
Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2020 earnings call dated Feb. 08, 2021 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K. Belanoff -- Chief
Merck & Co Inc (MRK) Q4 2020 Earnings Call
Merck & Co Inc (NYSE: MRK) Q4 2020 earnings call dated Feb. 04, 2021 Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations Kenneth C.
Cigna Corp (CI) Q4 2020 Earnings Call
Cigna Corp (NYSE: CI) Q4 2020 earnings call dated Feb. 04, 2021. Corporate Participants: Alexis Jones — Lead Principal, Investor Relations David Cordani — President and Chief
Eylea recovery, COVID antibody cocktail make Regeneron an attractive bet
After last year's mixed performance, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) looks to take advantage of the robust pipeline and the success of
Biogen, Inc. (BIIB) Q4 2020 Earnings Call
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief Executive Officer Alfred
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa — Vice President, Investor Relations Michael F. Mahoney — Chairman
Strong pipeline, M&A synergies to keep Bristol Myers on growth path
Bristol Myers Squibb Company (NYSE: BMY) is thriving on its multi-pronged growth plan, based on strategic acquisitions and the promising pipeline. Recently,
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2020 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q4 2020 earnings call dated Feb. 05, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations Leonard S.
Cardinal Health Inc. (CAH) Q2 2021 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q2 2021 earnings call dated Feb. 05, 2021 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Cigna Corp (CI) Q4 2020 Earnings Call Transcript
Cigna Corp (NYSE: CI) Q4 2020 earnings call dated Feb. 04, 2021. Corporate Participants: Alexis Jones -- Lead Principal, Investor Relations David Cordani -- President and
Bristol Myers (BMY) stock gains after Q4 results beat Street view
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company's stock gained in the pre-market session soon after the announcement.
Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged up 5%
Pfizer Inc. (PFE) Q4 2020 Earnings Call
Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano — Senior Vice President, Investor Relations Albert Bourla — Chairman
Humana Inc (HUM) Q4 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q4 2020 earnings call dated Feb. 03, 2021 Corporate participants: Amy K. Smith -- Vice President, Investor Relations Bruce D.
AbbVie Inc. (ABBV) Q4 2020 Earnings Call Transcript
AbbVie Inc. (NYSE: ABBV) Q4 2020 earnings call dated Feb. 03, 2021. Corporate Participants: Elizabeth Shea -- Vice President of Investor Relations Richard A.
Biogen, Inc. (BIIB) Q4 2020 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke -- Director, Investor Relations Michel Vounatsos -- Chief Executive Officer
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.